FGFR a promising druggable target in cancer: Molecular biology and new drugsRut Porta, Christian Rolfo, Pablo Reclusa et al.|Critical Reviews in Oncology/Hematology|2017Cited by 203
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancerUmberto Malapelle, Carlos Camps, Pasquale Pisapia et al.|Expert Review of Molecular Diagnostics|2017Cited by 171
Improving extracellular vesicles visualization: From static to motionPablo Reclusa|Scientific Reports|2020Cited by 55